Form D · Biotechnology
Fio Corp
Toronto, A6 · CIK 0001505558
Offering snapshot reported Dec 19, 2016 · SEC filing
- Reported sold
- $8.28M Offering amount: $8.28M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 6, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 19, 2016 | Initial | $8,282,230 | No comparison | 6 | SEC filing |
| Oct 20, 2015 | Initial | $75,680 | No comparison | 1 | SEC filing |
| Jan 28, 2015 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Oct 8, 2014 | Initial | $704,765 | No comparison | 3 | SEC filing |
| Jun 25, 2014 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Feb 6, 2013 | Initial | $255,781 | No comparison | 1 | SEC filing |
| Feb 6, 2013 | Initial | $50,070 | No comparison | 1 | SEC filing |
| Sep 1, 2011 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Nov 12, 2010 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-276525
The total offering amount is reflected in US dollars on the date of sale. Of the total offering amount, $900,128 was sold to six US investors.
Source: Form D, filed Dec 19, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| R. Michael Craig | Executive |
| Michael Craig | Executive |
| Shlomit Dekel | Director |
| Robert Friedland | Director |
| Michael Mordinson Greenberg | Director, Executive |
| Michael Mordinson Greenberg, Md | Director, Executive |
| Kerri Reid | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
111 Queen Street East, Suite 500
Toronto, A6, M5C 1S2
Toronto, A6, M5C 1S2